ImageProVision continues to expand its global presence and strengthen its leadership in AI-driven analytical solutions for the pharmaceutical industry, reaching over 517 installations worldwide. A major highlight is the advancement of the MICROBE AI-400, an AI-powered automated colony counter that improves accuracy, traceability, and regulatory compliance while enabling automatic differentiation between bacterial and fungal colonies. This innovation reflects the company’s commitment to modernizing microbiological workflows and supporting data integrity aligned with global regulatory standards.
In addition to product innovation, ImageProVision actively engaged with the pharmaceutical community through industry events such as DISSO India 2025 and CLAIRITY CONNECT, where the CLAIRITY™ Suite was showcased through live demonstrations and real-world applications. The company also conducted multiple customer training programs to enhance expertise in particle characterization and microscopic image analysis, helping laboratories improve analytical accuracy, efficiency, and quality. These efforts reinforce ImageProVision’s mission to deliver intelligent automation solutions that empower pharmaceutical laboratories worldwide.
Newsletter Link: https://drive.google.com/file/d/14OLfxYRUkFCYWF6NyxOvoshbTUj-5C1K/view?usp=sharing
